Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 266

1.

Anti-Platelet Antibodies in Childhood Immune Thrombocytopenia: Prevalence and Prognostic Implications.

Schmidt DE, Heitink-Polle KMJ, Porcelijn L, van der Schoot CE, Vidarsson G, Bruin MCA, de Haas M.

J Thromb Haemost. 2020 Feb 13. doi: 10.1111/jth.14762. [Epub ahead of print]

PMID:
32053276
2.

Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.

M C Ree I, Lopriore E, Zwiers C, Böhringer S, W M Janssen M, Oepkes D, DE Haas M.

Am J Obstet Gynecol. 2020 Jan 21. pii: S0002-9378(20)30036-3. doi: 10.1016/j.ajog.2020.01.028. [Epub ahead of print]

PMID:
31978433
3.

Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia.

de Vos TW, Winkelhorst D, de Haas M, Lopriore E, Oepkes D.

Transfus Apher Sci. 2019 Dec 31:102704. doi: 10.1016/j.transci.2019.102704. [Epub ahead of print] Review.

4.

The influence of motion artefacts on magnetic resonance imaging of the clavicles for age estimation.

De Tobel J, van Wijk M, Alberink I, Hillewig E, Phlypo I, van Rijn RR, Thevissen PW, Verstraete KL, de Haas MB.

Int J Legal Med. 2020 Jan 8. doi: 10.1007/s00414-019-02230-x. [Epub ahead of print]

PMID:
31915965
5.

Progress and development of platelet antibody detection.

Porcelijn L, Huiskes E, de Haas M.

Transfus Apher Sci. 2019 Dec 31:102705. doi: 10.1016/j.transci.2019.102705. [Epub ahead of print] Review.

6.

Knowledge, attitude and practices of obstetric care providers towards maternal red-blood-cell immunization during pregnancy.

Slootweg YM, Walg C, Koelewijn JM, Van Kamp IL, De Haas M.

Vox Sang. 2019 Dec 29. doi: 10.1111/vox.12883. [Epub ahead of print]

PMID:
31884705
7.

Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies.

Koelewijn JM, Slootweg YM, Folman C, van Kamp IL, Oepkes D, de Haas M.

Transfusion. 2020 Feb;60(2):391-399. doi: 10.1111/trf.15631. Epub 2019 Dec 23.

PMID:
31867744
8.

Necrotizing enterocolitis in haemolytic disease of the newborn: a retrospective cohort study.

Ree IMC, de Grauw AM, Bekker V, de Haas M, Te Pas AB, Oepkes D, Middeldorp AJM, Lopriore E.

Vox Sang. 2020 Feb;115(2):196-201. doi: 10.1111/vox.12862. Epub 2019 Dec 19.

PMID:
31858620
9.

Multi-factorial age estimation: A Bayesian approach combining dental and skeletal magnetic resonance imaging.

De Tobel J, Fieuws S, Hillewig E, Phlypo I, van Wijk M, de Haas MB, Politis C, Verstraete KL, Thevissen PW.

Forensic Sci Int. 2020 Jan;306:110054. doi: 10.1016/j.forsciint.2019.110054. Epub 2019 Nov 15.

PMID:
31778924
10.

Lateral Process Fracture of the Talus: A Case Series and Review of the Literature.

Wijers O, Posthuma JJ, De Haas MBJ, Halm JA, Schepers T.

J Foot Ankle Surg. 2020 Jan - Feb;59(1):136-141. doi: 10.1053/j.jfas.2019.02.003. Epub 2019 Oct 25.

PMID:
31668959
11.

FluoroTome 1: An Apparatus for Tomographic Imaging of Radio-Fluorogenic (RFG) Gels.

Warman JM, de Haas MP, Luthjens LH, Yao T, Navarro-Campos J, Yuksel S, Aarts J, Thiele S, Houter J, In Het Zandt W.

Polymers (Basel). 2019 Oct 23;11(11). pii: E1729. doi: 10.3390/polym11111729.

12.

Genetic Variation in Low-To-Medium-Affinity Fcγ Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine.

Nagelkerke SQ, Schmidt DE, de Haas M, Kuijpers TW.

Front Immunol. 2019 Oct 3;10:2237. doi: 10.3389/fimmu.2019.02237. eCollection 2019. Review.

13.

Staging Clavicular Development on MRI: Pitfalls and Suggestions for Age Estimation.

De Tobel J, Hillewig E, van Wijk M, Fieuws S, de Haas MB, van Rijn RR, Thevissen PW, Verstraete KL.

J Magn Reson Imaging. 2020 Feb;51(2):377-388. doi: 10.1002/jmri.26889. Epub 2019 Aug 1.

PMID:
31373087
14.

Anti-glycoprotein Ibα autoantibodies do not impair circulating thrombopoietin levels in immune thrombocytopenia patients.

Porcelijn L, Schmidt DE, van der Schoot CE, Vidarsson G, de Haas M, Kapur R.

Haematologica. 2019 Jul 11. pii: haematol.2019.228908. doi: 10.3324/haematol.2019.228908. [Epub ahead of print]

15.

Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms.

Schmidt DE, Heitink-Pollé KMJ, Laarhoven AG, Bruin MCA, Veldhuisen B, Nagelkerke SQ, Kuijpers TW, Porcelijn L, van der Schoot CE, Vidarsson G, de Haas M.

Blood Adv. 2019 Jul 9;3(13):2003-2012. doi: 10.1182/bloodadvances.2019000068.

16.

High-throughput identification of human SNPs affecting regulatory element activity.

van Arensbergen J, Pagie L, FitzPatrick VD, de Haas M, Baltissen MP, Comoglio F, van der Weide RH, Teunissen H, Võsa U, Franke L, de Wit E, Vermeulen M, Bussemaker HJ, van Steensel B.

Nat Genet. 2019 Jul;51(7):1160-1169. doi: 10.1038/s41588-019-0455-2. Epub 2019 Jun 28.

17.

Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells.

Baas I, Delvasto-Nuñez L, Ligthart P, Brouwer C, Folman C, Reis ES, Ricklin D, Lambris JD, Wouters D, de Haas M, Jongerius I, Zeerleder SS.

Haematologica. 2020 Jan 31;105(2):e57-e60. doi: 10.3324/haematol.2019.216028. Print 2020. No abstract available.

18.

Predicting anaemia and transfusion dependency in severe alloimmune haemolytic disease of the fetus and newborn in the first 3 months after birth.

Ree IMC, de Haas M, Middelburg RA, Zwiers C, Oepkes D, van der Bom JG, Lopriore E.

Br J Haematol. 2019 Aug;186(4):565-573. doi: 10.1111/bjh.15962. Epub 2019 May 29.

PMID:
31140599
19.

Neonatal Alloimmune Neutropenia.

Porcelijn L, de Haas M.

Transfus Med Hemother. 2018 Oct;45(5):311-316. doi: 10.1159/000492949. Epub 2018 Sep 24. Review.

20.

A Radio-Fluorogenic Polymer-Gel Makes Fixed Fluorescent Images of Complex Radiation Fields.

Warman JM, De Haas MP, Luthjens LH, Denkova AG, Yao T.

Polymers (Basel). 2018 Jun 20;10(6). pii: E685. doi: 10.3390/polym10060685. Review.

21.

Plasma thrombopoietin levels as additional tool in clinical management of thrombocytopenic neonates.

Porcelijn L, Huiskes E, Onderwater-Van Den Hoogen L, Folman CC, Zwaginga JJ, De Haas M.

Platelets. 2020;31(1):62-67. doi: 10.1080/09537104.2019.1572877. Epub 2019 Feb 13.

PMID:
30759044
22.

Forensic age estimation based on T1 SE and VIBE wrist MRI: do a one-fits-all staging technique and age estimation model apply?

De Tobel J, Hillewig E, de Haas MB, Van Eeckhout B, Fieuws S, Thevissen PW, Verstraete KL.

Eur Radiol. 2019 Jun;29(6):2924-2935. doi: 10.1007/s00330-018-5944-7. Epub 2019 Jan 7.

PMID:
30617494
23.

International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology: Report of the Dubai, Copenhagen and Toronto meetings.

Storry JR, Clausen FB, Castilho L, Chen Q, Daniels G, Denomme G, Flegel WA, Gassner C, de Haas M, Hyland C, Yanli J, Keller M, Lomas-Francis C, Nogues N, Olsson ML, Peyrard T, van der Schoot E, Tani Y, Thornton N, Wagner F, Weinstock C, Wendel S, Westhoff C, Yahalom V.

Vox Sang. 2019 Jan;114(1):95-102. doi: 10.1111/vox.12717. Epub 2018 Nov 12.

24.

Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.

Rijkers M, Schmidt D, Lu N, Kramer CSM, Heidt S, Mulder A, Porcelijn L, Claas FHJ, Leebeek FWG, Jansen AJG, Jongerius I, Zeerleder SS, Vidarsson G, Voorberg J, de Haas M.

Haematologica. 2019 Feb;104(2):403-416. doi: 10.3324/haematol.2018.201665. Epub 2018 Sep 27.

25.

The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization.

Zwiers C, Oepkes D, Lopriore E, Klumper FJ, de Haas M, van Kamp IL.

Prenat Diagn. 2018 Nov;38(12):943-950. doi: 10.1002/pd.5355. Epub 2018 Sep 27.

26.

Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.

Slootweg YM, Lindenburg IT, Koelewijn JM, Van Kamp IL, Oepkes D, De Haas M.

Am J Obstet Gynecol. 2018 Oct;219(4):393.e1-393.e8. doi: 10.1016/j.ajog.2018.07.020. Epub 2018 Jul 29.

PMID:
30063902
27.

Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial.

Heitink-Pollé KMJ, Uiterwaal CSPM, Porcelijn L, Tamminga RYJ, Smiers FJ, van Woerden NL, Wesseling J, Vidarsson G, Laarhoven AG, de Haas M, Bruin MCA; TIKI Investigators.

Blood. 2018 Aug 30;132(9):883-891. doi: 10.1182/blood-2018-02-830844. Epub 2018 Jun 26.

PMID:
29945954
28.

Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.

Zwiers C, van der Bom JG, van Kamp IL, van Geloven N, Lopriore E, Smoleniec J, Devlieger R, Sim PE, Ledingham MA, Tiblad E, Moise KJ Jr, Gloning KP, Kilby MD, Overton TG, Jørgensen DS, Schou KV, Paek B, Walker M, Parry E, Oepkes D, de Haas M.

Am J Obstet Gynecol. 2018 Sep;219(3):291.e1-291.e9. doi: 10.1016/j.ajog.2018.06.007. Epub 2018 Jun 11.

PMID:
29902448
29.

A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation.

Rijkers M, Saris A, Heidt S, Mulder A, Porcelijn L, Claas FHJ, Bierings R, Leebeek FWG, Jansen AJG, Vidarsson G, Voorberg J, de Haas M.

Haematologica. 2018 Oct;103(10):1741-1752. doi: 10.3324/haematol.2018.189365. Epub 2018 Jun 1.

30.

Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art.

Porcelijn L, Huiskes E, Oldert G, Schipperus M, Zwaginga JJ, de Haas M.

Br J Haematol. 2018 Aug;182(3):423-426. doi: 10.1111/bjh.15404. Epub 2018 May 29.

PMID:
29808904
31.

Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks.

Brinkman EK, Chen T, de Haas M, Holland HA, Akhtar W, van Steensel B.

Mol Cell. 2018 Jun 7;70(5):801-813.e6. doi: 10.1016/j.molcel.2018.04.016. Epub 2018 May 24.

32.

Treatment and outcomes of fetal/neonatal alloimmune thrombocytopenia: a nationwide cohort study in newly detected cases.

Winkelhorst D, Oostweegel M, Porcelijn L, Middelburg RA, Zwaginga JJ, Oepkes D, van der Bom JG, de Haas M, Lopriore E.

Br J Haematol. 2019 Mar;184(6):1026-1029. doi: 10.1111/bjh.15216. Epub 2018 Apr 16. No abstract available.

PMID:
29682737
33.

ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy.

Zwiers C, Koelewijn JM, Vermij L, van Sambeeck J, Oepkes D, de Haas M, van der Schoot CE.

Transfusion. 2018 Jul;58(7):1611-1617. doi: 10.1111/trf.14606. Epub 2018 Apr 6.

PMID:
29624682
34.

Immunoglobulin for alloimmune hemolytic disease in neonates.

Zwiers C, Scheffer-Rath ME, Lopriore E, de Haas M, Liley HG.

Cochrane Database Syst Rev. 2018 Mar 18;3:CD003313. doi: 10.1002/14651858.CD003313.pub2. Review.

35.

Facilitators and barriers for RhD-immunized women to become and remain anti-D donors.

Slootweg YM, Koelewijn JM, de Kort WL, de Haas M, Merz EM.

Transfusion. 2018 Apr;58(4):960-968. doi: 10.1111/trf.14490. Epub 2018 Mar 12.

PMID:
29532485
36.

Acute hemolytic transfusion reaction due to a warm reactive anti-A1.

Helmich F, Baas I, Ligthart P, Bosch M, Jonkers F, de Haas M, van der Graaf F.

Transfusion. 2018 May;58(5):1163-1170. doi: 10.1111/trf.14537. Epub 2018 Feb 26.

PMID:
29484668
37.

Human IgG lacking effector functions demonstrate lower FcRn-binding and reduced transplacental transport.

Stapleton NM, Armstrong-Fisher SS, Andersen JT, van der Schoot CE, Porter C, Page KR, Falconer D, de Haas M, Williamson LM, Clark MR, Vidarsson G, Armour KL.

Mol Immunol. 2018 Mar;95:1-9. doi: 10.1016/j.molimm.2018.01.006. Epub 2018 Feb 20.

38.

Human and murine splenic neutrophils are potent phagocytes of IgG-opsonized red blood cells.

Meinderts SM, Oldenborg PA, Beuger BM, Klei TRL, Johansson J, Kuijpers TW, Matozaki T, Huisman EJ, de Haas M, van den Berg TK, van Bruggen R.

Blood Adv. 2017 May 26;1(14):875-886. doi: 10.1182/bloodadvances.2017004671. eCollection 2017 Jun 13.

39.

Guidelines for Designing Social Robots as Second Language Tutors.

Belpaeme T, Vogt P, van den Berghe R, Bergmann K, Göksun T, de Haas M, Kanero J, Kennedy J, Küntay AC, Oudgenoeg-Paz O, Papadopoulos F, Schodde T, Verhagen J, Wallbridge CD, Willemsen B, de Wit J, Geçkin V, Hoffmann L, Kopp S, Krahmer E, Mamus E, Montanier JM, Oranç C, Pandey AK.

Int J Soc Robot. 2018;10(3):325-341. doi: 10.1007/s12369-018-0467-6. Epub 2018 Jan 25.

40.

Vox Sanguinis International Forum on application of fetal blood grouping: summary.

Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM.

Vox Sang. 2018 Feb;113(2):198-201. doi: 10.1111/vox.12616. Epub 2017 Dec 28. No abstract available.

PMID:
29282745
41.

Vox Sanguinis International Forum on application of fetal blood grouping.

Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM.

Vox Sang. 2018 Feb;113(2):e26-e35. doi: 10.1111/vox.12615. Epub 2017 Dec 28. No abstract available.

PMID:
29282741
42.

Genotyping to prevent Rh disease: has the time come?

van der Schoot CE, de Haas M, Clausen FB.

Curr Opin Hematol. 2017 Nov;24(6):544-550. doi: 10.1097/MOH.0000000000000379. Review.

PMID:
28937404
43.

Massive reshaping of genome-nuclear lamina interactions during oncogene-induced senescence.

Lenain C, de Graaf CA, Pagie L, Visser NL, de Haas M, de Vries SS, Peric-Hupkes D, van Steensel B, Peeper DS.

Genome Res. 2017 Oct;27(10):1634-1644. doi: 10.1101/gr.225763.117. Epub 2017 Sep 15.

44.

Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation.

Sonneveld ME, de Haas M, Koeleman C, de Haan N, Zeerleder SS, Ligthart PC, Wuhrer M, van der Schoot CE, Vidarsson G.

Sci Rep. 2017 Aug 15;7(1):8187. doi: 10.1038/s41598-017-08654-y.

45.

Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients.

Porcelijn L, Huiskes E, Schipperus M, van der Holt B, de Haas M, Zwaginga JJ; Dutch HOVON 64 Study Group.

Blood. 2017 Jun 22;129(25):3389-3391. doi: 10.1182/blood-2016-11-751719. Epub 2017 May 3. No abstract available.

PMID:
28468795
46.

Absence of the spleen and the occurrence of primary red cell alloimmunization in humans.

Evers D, van der Bom JG, Tijmensen J, de Haas M, Middelburg RA, de Vooght KMK, van de Kerkhof D, Visser O, Péquériaux NCV, Hudig F, Zwaginga JJ.

Haematologica. 2017 Aug;102(8):e289-e292. doi: 10.3324/haematol.2016.162685. Epub 2017 Apr 14. No abstract available.

47.

Women's attitude towards routine human platelet antigen-screening in pregnancy.

Winkelhorst D, Loeff RM, van den Akker-Van Marle ME, de Haas M, Oepkes D.

Acta Obstet Gynecol Scand. 2017 Aug;96(8):991-997. doi: 10.1111/aogs.13150. Epub 2017 May 16.

PMID:
28401538
48.

Child-Robot Interactions for Second Language Tutoring to Preschool Children.

Vogt P, de Haas M, de Jong C, Baxter P, Krahmer E.

Front Hum Neurosci. 2017 Mar 2;11:73. doi: 10.3389/fnhum.2017.00073. eCollection 2017.

49.

RhIg-prophylaxis is not influenced by FCGR2/3 polymorphisms involved in red blood cell clearance.

Stegmann TC, Veldhuisen B, Nagelkerke SQ, Winkelhorst D, Schonewille H, Verduin EP, Kuijpers TW, de Haas M, Vidarsson G, van der Schoot CE.

Blood. 2017 Feb 23;129(8):1045-1048. doi: 10.1182/blood-2016-05-716365. Epub 2017 Jan 12. No abstract available.

PMID:
28082442
50.

Genome-wide mapping of autonomous promoter activity in human cells.

van Arensbergen J, FitzPatrick VD, de Haas M, Pagie L, Sluimer J, Bussemaker HJ, van Steensel B.

Nat Biotechnol. 2017 Feb;35(2):145-153. doi: 10.1038/nbt.3754. Epub 2016 Dec 26.

Supplemental Content

Loading ...
Support Center